Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 USD | -2.07% | -4.05% | -24.47% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 1.5M | Capitalization | 93.55M |
---|---|---|---|---|---|
Net income 2024 * | -105M | Net income 2025 * | -130M | EV / Sales 2024 * | - |
Net cash position 2024 * | 36.5M | Net cash position 2025 * | 265M | EV / Sales 2025 * | -115 x |
P/E ratio 2024 * |
-1.03
x | P/E ratio 2025 * |
-1.04
x | Employees | 68 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.05% |
Latest transcript on IO Biotech, Inc.
1 day | -2.07% | ||
1 week | -4.05% | ||
Current month | -17.92% | ||
1 month | -15.73% | ||
3 months | -20.67% | ||
6 months | +57.78% | ||
Current year | -24.47% |
Managers | Title | Age | Since |
---|---|---|---|
Mai-Britt Zocca
FOU | Founder | 56 | 14-11-30 |
Amy Sullivan
DFI | Director of Finance/CFO | 54 | 22-10-14 |
Eric Faulkner
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Smith
BRD | Director/Board Member | 64 | 22-02-28 |
K. Hirth
CHM | Chairman | 72 | 16-08-31 |
Kathleen Glaub
BRD | Director/Board Member | 70 | 18-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.42 | -2.07% | 73,378 |
24-04-25 | 1.45 | -0.68% | 47,203 |
24-04-24 | 1.46 | -0.68% | 57,252 |
24-04-23 | 1.47 | +2.08% | 58,974 |
24-04-22 | 1.44 | -2.70% | 78,243 |
Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.47% | 95.53M | |
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |
- Stock Market
- Equities
- IOBT Stock